ConductScience.org, home

Paper33596235

Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.

Freidel MR and 1 other. PLoS One, 2021. Cited by 22 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase. Papers, record 33596235. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33596235

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
PubMed
Journal
PLoS One
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
1.35
iCite
Revised in PubMed
2022-12-07
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Freidel MRMatthew R
2Armen RSRoger Shttps://orcid.org/0000-0003-3830-1450

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
COVID-19Major topic
Coronavirus RNA-Dependent RNA PolymeraseMajor topic
MethyltransferasesMajor topic
RNA HelicasesMajor topic
SARS-CoV-2Major topic
Viral Nonstructural ProteinsMajor topic
Allosteric Site
Binding Sites
Computational Biology
Coronavirus 3C Proteases
Humans
Models, Molecular
Molecular Targeted Therapy
Protein Binding
RNA-Dependent RNA Polymerase
Virus Replication
COVID-19 Drug Treatment

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 HL114471NHLBI NIH HHSUnited StatesP01HL114471PubMed and NIHNIH RePORTER
R01 AR077666NIAMS NIH HHSUnited StatesR01AR077666PubMed and NIHNIH RePORTER
1P01HL114471-06NIH HHSUnited StatesP01HL114471PubMed and NIHNIH RePORTER

Download CSV of grants

References113

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132359479COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives.Trends Mol Med2020https://conductscience.org/library/papers/32359479PubMed
226655740Detection of secondary binding sites in proteins using fragment screening.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/26655740PubMed
319495994Lessons for fragment library design: analysis of output from multiple screening campaigns.J Comput Aided Mol Des2009https://conductscience.org/library/papers/19495994PubMed
419441289Sinefungin-PLGA nanoparticles: drug loading, characterization, in vitro drug release and in vivo studies.J Nanosci Nanotechnol2009https://conductscience.org/library/papers/19441289PubMed
532946692Structural Insights into the Binding Modes of Viral RNA-Dependent RNA Polymerases Using a Function-Site Interaction Fingerprint Method for RNA Virus Drug Discovery.J Proteome Res2020https://conductscience.org/library/papers/32946692PubMed
68340918Multiple copy simultaneous search and construction of ligands in binding sites: application to inhibitors of HIV-1 aspartic proteinase.J Med Chem1993https://conductscience.org/library/papers/8340918PubMed
721726192Receptor-based pharmacophore and pharmacophore key descriptors for virtual screening and QSAR modeling.Curr Comput Aided Drug Des2011https://conductscience.org/library/papers/21726192PubMed
830371825PubChem 2019 update: improved access to chemical data.Nucleic Acids Res2019https://conductscience.org/library/papers/30371825PubMed
932210130Evolutionary Trajectory for the Emergence of Novel Coronavirus SARS-CoV-2.Pathogens2020https://conductscience.org/library/papers/32210130PubMed
1025810418Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease.Clin Microbiol Rev2015https://conductscience.org/library/papers/25810418PubMed
1132360231Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein.Int J Antimicrob Agents2020https://conductscience.org/library/papers/32360231PubMed
1221644546
Evaluation of several two-step scoring functions based on linear interaction energy, effective ligand size, and empirical pair potentials for prediction of protein-ligand binding geometry and free energy.
J Chem Inf Model2011https://conductscience.org/library/papers/21644546PubMed
1318380424Ligand binding efficiency: trends, physical basis, and implications.J Med Chem2008https://conductscience.org/library/papers/18380424PubMed
1425709029Binding site druggability assessment in fragment-based drug design.Methods Mol Biol2015https://conductscience.org/library/papers/25709029PubMed
1525050323Sinefungin, a natural nucleoside analogue of S-adenosylmethionine, inhibits Streptococcus pneumoniae biofilm growth.Biomed Res Int2014https://conductscience.org/library/papers/25050323PubMed
1623023261Discovery of an allosteric mechanism for the regulation of HCV NS3 protein function.Nat Chem Biol2012https://conductscience.org/library/papers/23023261PubMed
17186628784-(1,1-Dioxo-1,4-dihydro-1lambda6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase.Bioorg Med Chem Lett2008https://conductscience.org/library/papers/18662878PubMed
18659406Sinefungin, a potent inhibitor of virion mRNA(guanine-7-)-methyltransferase, mRNA(nucleoside-2'-)-methyltransferase, and viral multiplication.J Biol Chem1978https://conductscience.org/library/papers/659406PubMed
1927939283Global vision of druggability issues: applications and perspectives.Drug Discov Today2017https://conductscience.org/library/papers/27939283PubMed
2032200634Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1.J Proteome Res2020https://conductscience.org/library/papers/32200634PubMed

See all 113 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
42071119The architecture of computational antiviralism: a multi-scale framework from molecular targeting to viral ecosystem engineering.Mol Divers2026https://conductscience.org/library/papers/42071119PubMed
39910979Analogs of NIH Molecular Probe ML283 Are Potent SARS-CoV-2 Helicase Inhibitors.ACS Chem Biol2025https://conductscience.org/library/papers/39910979PubMed
38793593Research Progress on Spike-Dependent SARS-CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of Spike.Viruses2024https://conductscience.org/library/papers/38793593PubMed
38733424An Overview of SARS-CoV-2 Potential Targets, Inhibitors, and Computational Insights to Enrich the Promising Treatment Strategies.Curr Microbiol2024https://conductscience.org/library/papers/38733424PubMed
38675980The Dual-Targeted Fusion Inhibitor Clofazimine Binds to the S2 Segment of the SARS-CoV-2 Spike Protein.Viruses2024https://conductscience.org/library/papers/38675980PubMed
37519829Investigating novel thiazolyl-indazole derivatives as scaffolds for SARS-CoV-2 MPro inhibitors.Eur J Med Chem Rep2022https://conductscience.org/library/papers/37519829PubMed
36561139Therapeutic potential of compounds targeting SARS-CoV-2 helicase.Front Chem2022https://conductscience.org/library/papers/36561139PubMed
36125417Structural Reshaping of the Zinc-Finger Domain of the SARS-CoV-2 nsp13 Protein Using Bismuth(III) Ions: A Multilevel Computational Study.Inorg Chem2022https://conductscience.org/library/papers/36125417PubMed
35887049Potential COVID-19 Therapies from Computational Repurposing of Drugs and Natural Products against the SARS-CoV-2 Helicase.Int J Mol Sci2022https://conductscience.org/library/papers/35887049PubMed
34898207Modeling the Structure-Activity Relationship of Arbidol Derivatives and Other SARS-CoV-2 Fusion Inhibitors Targeting the S2 Segment of the Spike Protein.J Chem Inf Model2021https://conductscience.org/library/papers/34898207PubMed
34861942RNA helicases required for viral propagation in humans.Enzymes2021https://conductscience.org/library/papers/34861942PubMed
34777769Modelling the active SARS-CoV-2 helicase complex as a basis for structure-based inhibitor design.Chem Sci2021https://conductscience.org/library/papers/34777769PubMed

Download CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
DNAH81769PubTator's text mininghttps://conductscience.org/library/genes/1769NCBI Gene
GP22813PubTator's text mininghttps://conductscience.org/library/genes/2813NCBI Gene
GTPBP19567PubTator's text mininghttps://conductscience.org/library/genes/9567NCBI Gene
HFM1164045PubTator's text mininghttps://conductscience.org/library/genes/164045NCBI Gene
RAD515888PubTator's text mininghttps://conductscience.org/library/genes/5888NCBI Gene
SPECC192521PubTator's text mininghttps://conductscience.org/library/genes/92521NCBI Gene
UPF15976PubTator's text mininghttps://conductscience.org/library/genes/5976NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33596235

GET https://conductscience.org/api/papers/v1/33596235/references?page=2